Bal Pharma Limited
NSE:BALPHARMA.NS
Overview | Financials
Company Name | Bal Pharma Limited |
Symbol | BALPHARMA.NS |
Currency | INR |
Price | 124.45 |
Market Cap | 1,981,356,005 |
Dividend Yield | 1.01% |
52-week-range | 88.95 - 157.98 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Shailesh Dheerajmal Siroya |
Website | https://www.balpharma.com |
An error occurred while fetching data.
About Bal Pharma Limited
Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD